SCHEMBL18555397

SCHEMBL18555397

O=C(C1CCCN1)N(F)CCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN4A P35499 1/20 0.45
CTSC P53634 1/20 0.44
HTR2C P28335 1/20 0.43
HTR2B P41595 1/20 0.43
OPRM1 P35372 3/20 0.39
OPRD1 P41143 3/20 0.39
OPRK1 P41145 3/20 0.39
TAAR1 Q96RJ0 3/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ELANE P08246 1/20 0.38
SLC18A3 Q16572 1/20 0.38
RAB9A P51151 3/20 0.37
EPHX2 P34913 2/20 0.37
TSHR P16473 2/20 0.37
NPC1 O15118 2/20 0.37
HTT P42858 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TP53 P04637 1/20 0.37
EPHX1 P07099 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13694071 0.80 GHSR (0.50) SCN4ACTSCPOLB
SCHEMBL13694045 0.80 GHSR (0.50) SCN4ACTSCPOLB
SCHEMBL10060310 0.79 MEN1 (0.49) SCN4ACTSCHTR2CHTR2BMEN1
SCHEMBL18142154 0.79 CTSC (0.49) CTSCHTR2CHTR2BTAAR1ELANE
Proline SCHEMBL9015317 0.78 CTSC (0.51) SCN4ACTSCHTR2CHTR2BTAAR1
Hydrochloric Acid SCHEMBL11100316 0.78 SCN4A (0.48) SCN4ACTSCHTR2CHTR2BMEN1
SCHEMBL13436116 0.77 MEN1 (0.53) SCN4ACTSCHTR2CHTR2BMEN1
SCHEMBL4677228 0.76 EPHX2 (0.49) CTSCHTR2CHTR2BMEN1KMT2A
SCHEMBL6968209 0.75 L3MBTL1 (0.48) SCN4ACTSCHTR2CHTR2BOPRM1
SCHEMBL7309838 0.75 SCN4A (0.47) SCN4ACTSCHTR2CHTR2BTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3340981-A1 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS Achillion Pharmaceuticals, Inc. (US) 2018-07-04 EP disclosed
WO-2017035353-A1 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2017-03-02 WO disclosed